Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial

BACKGROUND: Gastric cancer (GC) is a heterogenous disease consisted of several subtypes with distinct molecular traits. The clinical implication of molecular classification has been limited especially in association with treatment efficacy of ramucirumab or various targeted agents. METHODS: We condu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genome Med
Main Authors: Kim, Seung Tae, Sa, Jason K., Oh, Sung Yong, Kim, Kyung, Hong, Jung Yong, Kang, Won Ki, Kim, Kyoung-Mee, Lee, Jeeyun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836461/
https://ncbi.nlm.nih.gov/pubmed/33494793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-021-00826-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados